Clinical Trial Update: Study of Pazopanib and Ixabepilone in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of pazopanib plus ixabepilone in solid tumors was terminated; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colon Cancer
• Head and Neck Cancer
• Hepatocellular Cancer
• Kidney Cancer
• Lung Cancer
• Pancreatic Cancer
• Sarcoma

Drugs mentioned

• Ixabepilone (ixabepilone)
• Pazopanib (Pazopanib)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Breast Cancer, Lung Cancer | Phase 1 | Status: TERMINATED | Results posted: 2017-06-26